drugset / Trial / NCT02490176

Effects of Glucagon Like Peptide-1 on Haemodynamic Parameters

NCT02490176

Unknown 50 enrolled Chinese PLA General Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Glucagon-like peptide-1 (GLP-1) is an incretin hormone that regulates plasma glucose, and GLP-1 analogues were recently introduced for the treatment of acute myocardial infarction. The investigators planned to evaluate the effects of liraglutide on haemodynamic parameters in patients with heart failure.

Timeline

Start
2015-07
Primary completion
2016-07
Completion
2016-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Liraglutide Peptide 1.8 mg Subcutaneous

Indications